| Application no. and date | 11752700.2 (espacenet) (Federated) (European Patent Register), 20110824 | | Patent/reg. no. and date | DK/EP 2608792, 20171011 | | Publication date | 20130703 | | Priority no. and date | US 377177 P, 20100826 | | EP pub. no. and date |
EP 2608792 20130703 | | Effective date | | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Strasse 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 161109 | | Inventor | LORENCE, Robert Michael, Boehringer Ingelheim Pharmaceuticals Inc.
900 Ridgebury Road
P.O. Box 368
Ridgefield
Connecticut 06877-0368, US,
SHAHIDI, Mehdi, Boehringer Ingelheim Ltd UK
Ellesfield Avenue
Bracknell Berkshire RG12 8YS, GB,
STOPFER, Peter, Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216 Ingelheim am Rhein, DE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61K 31/5377 (2006.01) , A61P 35/00 (2006.01) | | Title | FREMGANGSMÅDER TIL INDGIVELSE AF EN EGFR-INHIBITOR. | | Int. application no. | US2011048922 | | Int. publication no. | WO2012027445 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
